Biological E's COVID-19 Vaccine Corbevax Gets Emergency Approval For 12-18 Age Group From DCGI
India's third homegrown Covid-19 vaccine, Corbevax will be administered in two doses, according to reports.
Hyderabad-based pharmaceutical company Biological E Ltd has said that its coronavirus vaccine Corbevax, also India's third homegrown vaccine, has received an emergency use approval in India From DCGI for use in children aged 12 to 18 years.
See Tweet:
Drugs Controller General of India (DCGI) grants final approval to Biological E's #COVID19 vaccine Corbevax, for children between 12-18 years of age. pic.twitter.com/2hBJpM3p40
— DD News (@DDNewslive) February 21, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)
(The above story first appeared on LatestLY on Feb 21, 2022 06:17 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
